Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castrate-resistant Prostate Cancer (CRPC)”

218 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 218 results

Testing effectiveness (Phase 2)Study completedNCT04060394
What this trial is testing

Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Laekna Limited 49
Testing effectiveness (Phase 2)Study completedNCT02952534
What this trial is testing

Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 277
Early research (Phase 1)Study completedNCT01497925
What this trial is testing

Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer

Who this might be right for
Solid TumorsProstate Cancer
Polaris Group 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT01688492
What this trial is testing

Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 54
Testing effectiveness (Phase 2)Looking for participantsNCT05458544
What this trial is testing

[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
FutureChem 26
Testing effectiveness (Phase 2)Study completedNCT00564928
What this trial is testing

Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer

Who this might be right for
Prostate CancerProstatic NeoplasmsCancer of the Prostate
Infinity Pharmaceuticals, Inc. 19
Very early researchNot Yet RecruitingNCT07052760
What this trial is testing

Imaging of Solid Tumors Using DLL3 SPECT

Who this might be right for
Solid Tumor CancerCastration Resistant Prostate CancerCastration Resistant Prostate Cancer (CRPC)+1 more
Thomas Hope 45
Testing effectiveness (Phase 2)Looking for participantsNCT07259213
What this trial is testing

Terbium 161 (161Tb)-RAD402 in Participants With CRPC

Who this might be right for
Castration-resistant Prostate Cancer
Radiopharm Theranostics, Ltd 73
Early research (Phase 1)Study completedNCT02578797
What this trial is testing

A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study

Who this might be right for
Castration-Resistant Prostate Cancer
Aragon Pharmaceuticals, Inc. 45
Early research (Phase 1)UnknownNCT04839991
What this trial is testing

Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.

Who this might be right for
Advanced and/or Metastatic Solid Tumours
Crescendo Biologics Ltd. 70
Testing effectiveness (Phase 2)Ended earlyNCT01499043
What this trial is testing

Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
Daiichi Sankyo 6
Not applicableUnknownNCT03786848
What this trial is testing

Personalized Mini-PDX for Metastatic CRPC

Who this might be right for
Prostate Cancer
Tianjin Medical University Second Hospital 15
Testing effectiveness (Phase 2)Study completedNCT02159950
What this trial is testing

Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+1 more
Roswell Park Cancer Institute 2
Not applicableStudy completedNCT04232761
What this trial is testing

Study to Gather Information on the Safety and How Radium-223 Dichloride, an Alpha Particle-emitting Radioactive Agent, Works Under Routine Clinical Practice in Taiwan in Patients With Castration-resistant Prostate Cancer (CRPC) Which Has Spread to the Bone

Who this might be right for
Castration-resistant Prostate Cancer
Bayer 194
Early research (Phase 1)Active Not RecruitingNCT07214961
What this trial is testing

Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer (CRPC)Metastatic Castrate Resistant Prostate Cancer (mCRPC)
ARTBIO Inc. 80
Early research (Phase 1)Looking for participantsNCT03460977
What this trial is testing

Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)Small Cell Lung Cancer (SCLC)Follicular Lymphoma (FL)
Pfizer 453
Testing effectiveness (Phase 2)Looking for participantsNCT06922318
What this trial is testing

The COSMYC Trial (COmbined Suppression of MYC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Testing effectiveness (Phase 2)Study completedNCT02825628
What this trial is testing

Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer Metastatic
DexTech Medical AB 55
Testing effectiveness (Phase 2)Ended earlyNCT01828476
What this trial is testing

Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 13
Not applicableStudy completedNCT02669147
What this trial is testing

Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC

Who this might be right for
Castration Resistant Prostate Cancer (CRPC)
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 160
Load More Results